Aktivax, Inc.
Dba Aktiv Pharma Group Use Cage Code
5D8w7 For Cataloging
CAGE Code: 9HK54
NCAGE Code: 9HK54
Status: Active
Type: Manufacturer
Summary
Aktivax, Inc., Dba Aktiv Pharma Group Use Cage Code, 5D8w7 For Cataloging is an Active Manufacturer with the Cage Code 9HK54.
Address
100 Technology Dr Ste 200A
Broomfield CO 80021-3692
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Sturgeon Electric Company, Inc. Phoenix Analytical Laboratories Inc Checkers Industrial Products, Llc Intelagard Inc Rf Micro Devices, Inc. Ellis Construction Specialists Ltd Wolven Engineering, Llc Flatiron Constructors, Inc. Mwh - Mcalvain, Joint Venture Rocky Flats Technical Associates Inc Photonics Research Inc Revolutionary Enterprises Llc Corporate Express Inc Envirotech Services Inc. Dba Enviro Computerized Pricing Systems Arapahoe Roofing And Sheet Metal Inc Altec Air, Llc Vixel Corp Rieckhoff Inc Rkm Construction Co Inc
Frequently Asked Questions (FAQ) for CAGE 9HK54
- What is CAGE Code 9HK54?
- 9HK54 is the unique identifier used by NATO Organizations to reference the physical entity known as Aktivax, Inc. Dba Aktiv Pharma Group Use Cage Code 5D8w7 For Cataloging located at 100 Technology Dr Ste 200A, Broomfield CO 80021-3692, United States.
- Who is CAGE Code 9HK54?
- 9HK54 refers to Aktivax, Inc. Dba Aktiv Pharma Group Use Cage Code 5D8w7 For Cataloging located at 100 Technology Dr Ste 200A, Broomfield CO 80021-3692, United States.
- Where is CAGE Code 9HK54 Located?
- CAGE Code 9HK54 is located in Broomfield, CO, USA.
Contracting History for CAGE 9HK54 Most Recent 25 Records
- 75A50122C00082
- This Acquisition Will Allow Barda To Invest Project Bioshield Funds For Late-Stage Clinical Development, Regulatory Approval For 2-Pam Autoinjectors (As A Drug/Device Combination Product) To Treat Organophosphate (Op) Poisoning, Including Nerve Agent
- 6 Dec 2023
- This Acquisition Will Allow Barda To Invest Project Bioshield Funds For Late-Stage Clinical Development, Regulatory Approval For 2-Pam Autoinjectors (As A Drug/Device Combination Product) To Treat Organophosphate (Op) Poisoning, Including Nerve Agent
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $45,323,792.00
- Department Of Health And Human Services (Hhs)